MATINAS BIOPHARMA HOLDINGS, INC. Conversion of Stock, Shares Converted
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Conversion of Stock, Shares Converted of 132.10 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2020-11-06
- MATINAS BIOPHARMA HOLDINGS, INC. conversion of stock, shares converted for the quarter ending 2020-09-30 was 75.60K shares.
- MATINAS BIOPHARMA HOLDINGS, INC. conversion of stock, shares converted for the quarter ending 2020-06-30 was 0.00 shares.
- MATINAS BIOPHARMA HOLDINGS, INC. conversion of stock, shares converted for the quarter ending 2020-03-31 was 56.50K shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month |
|---|---|---|---|
| 2020-09-30 | 75.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 75.60K shares derived: sum of 2 quarters · filed 2020-11-06 | 132.10K shares 10-Q · filed 2020-11-06 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 56.50K shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 56.50K shares 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |